In young children with cerebral palsy, infusion of autologous umbilical cord blood improves whole brain connectivity and motor function.
Significant improvements in muscle tone, spasticity, goal attainment, and overall clinical benefit were observed across all injection cycles.
While their are other factors more strongly associated with risk of cerebral palsy, maternal obesity is modifiable and therefore should be studied further.
The drug is the first botulinum toxin indicated for the treatment of lower limb spasticity in pediatric patients.
Causes other than asphyxia account for most cases of cerebral palsy in near-term infants.
Reduced brain connectivity puts preterm infants at a greater risk of developing neurodevelopmental disorders.
Compared with penicillin, macrolides taken during pregnancy increase the child's risk of developing cerebral palsy or epilepsy.
Researchers say 14% of cerebral palsy cases are likely to be caused by a genetic mutation.
Neurology Advisor Articles
- McDonald Criteria Update: Further Distinction Between Relapsing-Remitting, Primary-Progressive MS
- Distinct Clinical Characteristics of Headache Associated With Subarachnoid Hemorrhage
- Increased Epilepsy Risk Identified in Multiple Sclerosis
- Magnesium Plus Environmental Enrichment Boosts Cognition, Memory in Alzheimer's Mouse Model
- Prognostic Significance of Weight Loss in Patients With Early Parkinsonism
- Coffee Consumption May Decrease Stroke Risk
- When and How to Approach Driving Cessation in Patients With Dementia
- NBT System Gets FDA Clearance for Depression Treatment
- Erenumab, Fremanezumab Reduce Migraine Frequency, Burden
- Some Antiepileptic Drugs Associated With Increased Risk for Toxic Epidermal Necrolysis
- Obesity and Alzheimer Disease: Exploring Risk Modification
- Increased Amyloid Burden With Obstructive Sleep Apnea
- Vigabatrin Beneficial for Focal Seizures in Tuberous Sclerosis Complex
- Number of Americans With Alzheimer Disease Expected to More Than Double by 2060
- Deep Brain Stimulation Improves Survival in Parkinson Disease